DEXCOM INC 4

Dexcom Inc. EVP & CFO Jereme M. Sylvain sold 3,638 shares of DXCM common stock for roughly $303,000 under a Rule 10b5-1 trading plan.

On 2026-09-10, Dexcom Inc. EVP and Chief Financial Officer Jereme M. Sylvain sold 3,638 shares of Dexcom common stock at an average price of approximately $83.27 per share, for total proceeds of about $303,000. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted on 2026-06-10 to facilitate orderly dispositions of his holdings. Following this sale, Sylvain beneficially owned 146,828 shares of Dexcom common stock, a figure that includes 87,094 unvested restricted stock units with various grant and vesting schedules and 76 shares acquired under Dexcom’s Amended and Restated 2015 Employee Stock Purchase Plan, indicating that his remaining economic exposure to the company’s equity remains substantial despite the programmed sale.

Filing Facts

CIK

1093557

Ticker

DXCM

Form

4

Source Type

sec

Accession

0001093557-26-000173

Alert Tier

5